WealthCollab’s Novo Nordisk NVO Stock Holding History

WealthCollab’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$31.4K	Buy	656 +235	+56%	+$10.1K	0.01%	316
2026 Q1	$15.5K	Sell	421 -117	-22%	-$5.54K	0.01%	437
2025 Q4	$27.4K	Buy	538 +260	+94%	+$13.3K	0.01%	316
2025 Q3	$15.4K	Sell	278 -194	-41%	-$11.4K	0.01%	420
2025 Q2	$32.6K	Sell	472 -126	-21%	-$8.57K	0.02%	237
2025 Q1	$41.5K	Sell	598 -155	-21%	-$12.8K	0.03%	187
2024 Q4	$64.8K	Sell	753 -107	-12%	-$11.6K	0.04%	134
2024 Q3	$102K	Hold	860	–	–	0.07%	102
2024 Q2	$123K	Hold	860	–	–	0.09%	78
2024 Q1	$110K	Buy	860 +6	+0.7%	+$714	0.08%	83
2023 Q4	$88.3K	Buy	+854	New	+$84.5K	0.07%	95

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

WealthCollab's NVO Position: Q2 2026 in Review

WealthCollab increased its Novo Nordisk (NVO) stake by 56% in Q2 2026, buying an estimated $10.1K and bringing the position to 656 shares worth $31.4K. The position accounts for 0.01% of the portfolio, ranked #316.

WealthCollab first reported a position in NVO in Q4 2023 and has held it in 11 quarters since. The position peaked at $123K in Q2 2024. 1,355 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

WealthCollab held 656 shares of Novo Nordisk worth $31.4K as of Q2 2026.
WealthCollab bought 235 Novo Nordisk shares in Q2 2026, an estimated $10.1K.
Novo Nordisk made up 0.01% of WealthCollab's portfolio in Q2 2026, its #316 holding.
WealthCollab first reported a position in Novo Nordisk in Q4 2023 and has held it in 11 quarters since.
WealthCollab's Novo Nordisk position peaked at $123K in Q2 2024.
1,355 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on WealthCollab's 13F filing for Q2 2026, filed 10 Aug 2026.